Mitobronitol
WikiDoc Resources for Mitobronitol |
Articles |
---|
Most recent articles on Mitobronitol Most cited articles on Mitobronitol |
Media |
Powerpoint slides on Mitobronitol |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Mitobronitol at Clinical Trials.gov Clinical Trials on Mitobronitol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Mitobronitol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Mitobronitol Discussion groups on Mitobronitol Patient Handouts on Mitobronitol Directions to Hospitals Treating Mitobronitol Risk calculators and risk factors for Mitobronitol
|
Healthcare Provider Resources |
Causes & Risk Factors for Mitobronitol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Mitobronitol (1,6-dibromo-1,6-dideoxy-D-mannitol) is a brominated analog of mannitol. It is an anticancer drug that is classified as an alkylating agent.[1]
References
- ↑ Mitobronitol, The Centre for Cancer Education